HeartBeam records $3.5 million in operating expenses for Q3, focusing on cardiac arrest detection strategy
BEAT HeartBeam Inc
$0.40 -1.78%
View chart & analysis → - 1HeartBeam, Inc. reported cardiac arrest detection as a key strategic priority.
- 2HeartBeam's net cash used in operating activities for the quarter was $2.6 million.
- 3HeartBeam's cardiac platform opportunity market size within the healthcare industry reaches $40 billion.
So what's the key point?
HeartBeam spent $2.6 million this quarter while focusing on technology to detect cardiac arrest. The company is targeting a $40 billion market.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.